8-KLeadership ChangesRegulation FDExhibits & Filings

INTUITIVE SURGICAL INC 8-K Report, Executive Changes (Jul 29, 2019)

Filed July 29, 2019For Securities:ISRG

Summary

Intuitive Surgical, Inc. (ISRG) announced a board appointment and related compensation adjustments in an 8-K filing dated July 29, 2019. The company appointed Amy L. Ladd, M.D. to its Board of Directors and Compensation Committee, effective August 1, 2019. This appointment also resulted in an increase in the authorized number of board members from nine to ten. Dr. Ladd's compensation as a non-employee director includes an annual cash retainer and initial equity awards consisting of stock options and restricted stock units (RSUs). These awards are designed to align her interests with shareholders and vest over one year or by the next annual meeting, subject to continued service. The filing also confirms no reportable related-party transactions involving Dr. Ladd.

Key Highlights

  • 1Appointment of Amy L. Ladd, M.D. to the Board of Directors.
  • 2Appointment of Dr. Ladd to the Compensation Committee.
  • 3Expansion of the Board of Directors' authorized membership to ten members.
  • 4Dr. Ladd will receive an annual cash retainer of $66,000 for her board and committee service.
  • 5Dr. Ladd will receive initial equity grants valued at approximately $186,668 ($93,334 in stock options and $93,334 in RSUs).
  • 6Equity awards vest on the earlier of the first anniversary of the grant date or the next annual stockholder meeting, contingent on continued service.
  • 7No material direct or indirect interest requiring disclosure under Item 404(a) of Regulation S-K was reported for Dr. Ladd.

Frequently Asked Questions

Dr. Ladd's appointment, particularly to the Compensation Committee, suggests the board is potentially adding expertise relevant to executive compensation and corporate governance. Her equity awards are designed to align her interests with long-term shareholder value creation.

Dr. Ladd will receive an annual cash retainer of $66,000, comprising a $60,000 general board retainer and an additional $6,000 for her service on the Compensation Committee. This amount will be prorated for her service in 2019. Additionally, she will receive initial stock options and RSUs.

Dr. Ladd's stock options and RSUs will vest fully on the earlier of the first anniversary of the grant date or the next annual meeting of stockholders following the grant date, provided she continues to serve the Company through that date.

The filing explicitly states that there are no transactions in which Dr. Ladd had or will have a direct or indirect material interest that would require reporting under the relevant SEC regulations (Item 404(a) of Regulation S-K).